Glucotrack, Inc. — Form 8-K
Filed August 5, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
Glucotrack issued a senior secured convertible promissory note with 22% OID, 8% interest, 9-month maturity, and conversion at 80% of 15-day VWAP (subject to floor at 20% of Nasdaq minimum price). Also issued three warrant classes: (1) standard warrant exercisable at valuation-based price post-shareholder approval, (2) warrant exercisable at $1.50, and (3) pre-funded warrant at $0.001/share. All principal amounts left blank in filing; specific dollar figures and share counts are undefined. Security backed by first-priority lien on all company assets.
Why this rating
Highly dilutive financing with multiple conversion/exercise mechanics and blank principal terms signal capital stress. Heavy reliance on future shareholder approval and complex anti-dilution adjustments. At $5.4M market cap, any material draw is company-changing.
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.